Frequently Asked Questions
The COVID-19 pandemic affected the Rheumatoid Arthritis Therapeutics Market as well, which led to a reduction in revenue in 2020 as a result of the temporary suspension of numerous development projects and deals by various businesses.
North America accounted for the highest share in the global Rheumatoid Arthritis Therapeutics market.
The major factors driving the growth of the rheumatoid arthritis drugs market are the rise in rheumatoid arthritis prevalence, rise in demand for rheumatoid arthritis drugs, expiration of patents & the entry of biosimilar drugs, rise in geriatric population, rise in adoption of conventional DMARDs, and government initiatives to spread awareness of rheumatoid arthritis symptoms.
Biopharmaceuticals had a major share in 2021.
The Over-the-Counter (OTC)segment had a major share in the global market in 2021.